Searched for
DOMESTIC BUSINESS PERFORMANCE
Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 croreEmcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore....- KRBL shares rally 9% after Q2 net profit jumps 51% YoYKRBL shares jumped nearly 9% after the company reported a 51% rise in second-quarter profit, supported by strong domestic sales and improve...
- Institutional investors step up bets on private credit as insurers, pension funds and DFIs back new fundsInstitutional investors are now allocating more funds to private credit, significantly from insurance companies and pension funds. Neo Alte...
- Mahindra clocks all-time high SUV sales of 73,338 units in October on festive demandMahindra & Mahindra reported its highest ever monthly SUV sales in October 2026 with significant increases. Domestic utility vehicle sales ...
- Corporate offsites, incentive trips make a comeback as companies resume travel plansCorporate offsites and incentive trips are witnessing a revival as companies resume travel plans. Businesses are now scheduling deferred tr...
- Global business school applications fall 10%; Indian students increasingly turn to Europe, Asia: GMAC reportGlobal applications for graduate management education programmes declined by 10% for the 2026-27 class. Europe and Asia reported growth, wh...
- Oil-to-chemicals business powers Reliance Industries' record quarterly net profit, up 34% to ₹29,550 croreReliance Industries Ltd has set a new benchmark with a record net profit of ₹29,550 crore for the September quarter, fueled by significant ...
- Sun Pharma Q2 profit takes a hit on exceptional itemsSun Pharmaceutical has seen a notable 36% drop in net profit, juxtaposed with an 11.8% rise in consolidated revenue. The uplift in revenue ...
- Sun Pharma Q2 profit falls 36% as litigation costs hit earningsSun Pharma reported a 36% decline in Q2FY27 net profit to Rs 1,989 crore due to exceptional litigation and acquisition-related costs. Reven...
- Bank of Baroda Q2 Results: Standalone profit jumps 36% YoY to Rs 6,532 crore; NII up 9%Bank of Baroda reported a 35.8% year-on-year rise in standalone net profit to Rs 6,532 crore in Q2FY27. Net interest income grew 9% to Rs 1...
- Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional chargesSun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported...
- Diwali blues: 83 largecap stocks plunge up to 60% since Samvat 2082. Can bluechips light up D-Street in the new year?Indian equities enter Samvat 2083 after a volatile year and a sharp market correction. While lower valuations have improved the risk-reward...
- Adani Ports reports 18% net profit rise to Rs 3,682 crore in Q2 FY27Adani Ports and Special Economic Zone showcased a remarkable 18% increase in consolidated net profit for the September quarter. With a year...
- Cipla’s US recovery, biosimilar pipeline key to future growth prospectsCipla's September-quarter earnings suffered due to a high base in its US business. The company reported sequential growth driven by its str...
- Bajaj Auto Q2 Results: Profit jumps 35% YoY to Rs 3,354 crore; revenue up 34%Bajaj Auto Q2 Results: Revenue grew 34% YoY to Rs 20,003 crore for the first time, doubling over the past three years. The company also rep...
- Cipla Q2 net profit falls 35% to Rs 878 crore, revenue dips 2%Cipla reported a 35% year-on-year decline in second-quarter net profit to Rs 878 crore, with revenue and EBITDA also falling amid weaker No...
- Cipla expects US business to draw support from upcoming product pipelineCipla reported a significant decline in its consolidated net profit for the second quarter of FY27. The company's North American revenue fe...
- Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreMankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...
- Mankind Pharma Q2 profit rises 38% to Rs 716 croreMankind Pharma has announced a profit increase of 37.7% to ₹716 crore during the September quarter. Revenue from operations rose to ₹4,337....
- Dr Reddy's bets on generic semaglutide, biosimilarsDr Reddy's domestic formulations business grew in the September quarter, while Revlimid sales declined in North America. A relaunch of gene...
Load More
